CVS Health agrees to pay $37.8M to settle fraud allegations over insulin pens / Fierce
fiercehealthcare - CVS Health agreed to pay $37.76 million to settle allegations that it dispensed too many insulin pens to patients and improperly billed federal healthcare programs for those prescriptions.
#healthcare #pharmaceuticals #drugpricing #publichealth #corporatetakeover
Monday, December 8, 2025, 12:21 am / permalink 16679 / 2 stories in 3 months
Will All Newborns Still Receive Hepatitis B Shots? A Committee’s Vote Will Tell. / NYT
Apoorva Mandavilli / nytimes - The federal vaccine panel appointed by Health Secretary Robert F. Kennedy Jr. is likely to decide on Thursday that the shots should be delayed for infants whose mothers test negative for the virus.
#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety
Sunday, December 7, 2025, 10:22 am / permalink 16672 / 6 stories in 3 months
California Discourages Wild Mushroom Foraging After Fatal Outbreak / NYT
Hannah Ziegler / nytimes - Officials said one person was killed and 20 others were poisoned after eating death cap mushrooms, which look and taste like safe mushrooms but can cause liver failure.
#healthcare #publichealth #governmentpolicy
Saturday, December 6, 2025, 8:21 pm / permalink 16668 / 3 stories in 3 months
Startup Protego Bio Lands $130M for First-in-Class Drug’s Pivotal Test in Rare Plasma Disorder / MedCity
Frank Vinluan / medcitynews - Protego Biopharma’s lead program is a potential treatment for the rare disease light chain amyloidosis. The startup says the novel mechanism of its oral small molecule should have better outcomes than antibodies from AstraZeneca and Prothena that failed t…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment
Saturday, December 6, 2025, 10:21 am / permalink 16661 / 2 stories in 3 months
Volcanic eruptions may have brought Black Death to Europe / Medical Express
medicalxpress - Previously unknown volcanic eruptions may have kicked off an unlikely series of events that brought the Black Death—the most devastating pandemic in human history—to the shores of medieval Europe, new research has revealed.
Saturday, December 6, 2025, 7:21 am / permalink 16655 / 3 stories in 3 months
ACIP drops universal hepatitis B birth dose recommendation / Endpoints
Max Bayer / endpoints - A panel of CDC vaccine advisors has stopped recommending that all children receive the hepatitis B vaccine at birth, overruling scientific consensus and public health officials who pleaded that there was no grounded rationale for ...
#healthcare #publichealth #governmentpolicy #cdc #vaccinesafety
Friday, December 5, 2025, 11:22 am / permalink 16612 / 14 stories in 3 months
A dozen former FDA commissioners blast Prasad's proposed vaccine policy changes / Fierce
fiercehealthcare - Drastic overhauls of U.S. vaccine regulations proposed by top FDA official Vinay Prasad, M.D., have drawn harsh pushback from 12 former commissioners of the agency.
#healthcare #publichealth #governmentpolicy #biotech #drugdevelopment #fda #vaccinesafety
Thursday, December 4, 2025, 10:23 am / permalink 16565 / 10 stories in 3 months
FDA approves all ages gene therapy for spinal condition / Beckers
Ella Jeffries / beckershospitalreview - The FDA approved Novartis’ Itvisma (onasemnogene abeparvovec-brve), the company’s first and only gene replacement therapy for spinal muscular atrophy in children 2 and older, as well as for teens and adults. The therapy is designed to address the genetic …
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda
Monday, December 1, 2025, 4:21 am / permalink 16428 / 2 stories in 3 months
Novo submits high-dose Wegovy for FDA approval using voucher / Endpoints
Max Bayer / endpoints - Novo Nordisk submitted a higher dose of its obesity drug Wegovy for FDA approval and is using a recently-won voucher to expedite the review. The company said Wednesday that it submitted ...
#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #publichealth #biotech #drugdevelopment #fda
Saturday, November 29, 2025, 5:21 pm / permalink 16400 / 2 stories in 3 months
CASSANDRA-PACT-21 Trial Update: Preoperative PAXG vs mFOLFIRINOX in Resectable and Borderline Resectable PDAC / OncoDaily
oncodaily - The landscape of early-stage pancreatic ductal adenocarcinoma (PDAC) continues to evolve as clinicians move from surgery-first strategies toward perioperative treatment. Neoadjuvant and perioperative approaches have shown growing promise, yet no […]
#healthcare #pharmaceuticals #publichealth #drugdevelopment
Saturday, November 29, 2025, 9:21 am / permalink 16387 / 5 stories in 3 months
Tracking with care: The ethics of using location tracking technology with people living with dementia / Medical Express
medicalxpress - Imagine you're 83 years old, living with dementia in a long-term care home. Lately, your caregivers keep asking you to wear a bracelet on your wrist 24/7. They say it's for your safety, so they can locate you quickly when needed.
Saturday, November 29, 2025, 5:21 am / permalink 16384 / 2 stories in 3 months
Novo Nordisk GLP-1 fails to slow Alzheimer’s in trials / Beckers
Ella Jeffries / beckershospitalreview - Novo Nordisk’s GLP-1 drug semaglutide did not demonstrate a statistically significant effect in slowing progression of Alzheimer’s disease in two late-stage clinical trials. According to a Nov. 24 news release from the company, two double-blinded, placebo…
#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #publichealth #biotech #drugdevelopment
Tuesday, November 25, 2025, 10:21 am / permalink 16294 / 5 stories in 3 months
FDA Approves Pembrolizumab + Enfortumab Vedotin-ejfv for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer / OncoDaily
oncodaily - What Does FDA Approval Mean? The U.S. Food and Drug Administration (FDA) evaluates new cancer therapies to determine whether they are safe and effective for clinical use. Approval is based […]
#healthcare #pharmaceuticals #publichealth #drugdevelopment #fda
Monday, November 24, 2025, 10:23 am / permalink 16257 / 2 stories in 3 months
M. Tezer Kutluk: 2025 Update of World Cancer Declaration with UICC Board / OncoDaily
oncodaily - M. Tezer Kutluk, Professor of Pediatrics and Pediatric Oncologists, Chair of the Scientific Board at Medicana Health Group, shared a post on LinkedIn: “Dear friends, Between 18–20 November 2025 in Melbourne, […]
- Geriatric Oncology Updates (5)
- Global Cancer Leadership & Policy (9)
- Innovative Cancer Treatment & Research (16)
- Other Cancer & Related Topics (17)
Geriatric Oncology Updates
Global Cancer Leadership & Policy
Innovative Cancer Treatment & Research
Other Cancer & Related Topics
Monday, November 24, 2025, 4:21 am / permalink 16241 / 47 stories in 3 months
New nasal nanodrops wipe out brain tumors in mice / Science Daily Cancer
sciencedaily - A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune pathway using gold-core spherical nucleic acids, researchers were able to reach the brain without invasive surgery. When paired with dru…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment
Saturday, November 22, 2025, 1:21 pm / permalink 16217 / 3 stories in 3 months
Medicare premiums set to rise 10% next year, CMS says / Healthcare Dive
Rebecca Pifer / healthcaredive - The Part B premium hike could have been worse, the Trump administration said. Still, it’s likely to pressure the pocketbooks of millions of seniors, and could drive more into Medicare Advantage plans.
#healthcare #publichealth #governmentpolicy
Saturday, November 22, 2025, 9:22 am / permalink 16211 / 2 stories in 3 months
FDA Approves Ziftomenib for Relapsed or Refractory Acute Myeloid Leukaemia with a NPM1 Mutation / ESMO
esmo - Evidence for efficacy is based on the results from the KO-MEN-001 study
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #fda
Saturday, November 22, 2025, 9:22 am / permalink 16210 / 2 stories in 3 months
New Flu Strain and Low Vaccination Rates Could Mean Aggressive Flu Season Ahead / Discover
discovermagazine - Starting in 2025, this year’s flu season is spreading early, and with vaccination rates low and a novel virus strain, health experts are warning that it could be a rough one.
#healthcare #publichealth #cdc #vaccinesafety
Saturday, November 22, 2025, 5:21 am / permalink 16206 / 4 stories in 3 months
CMS issues new telehealth guidance: 4 notes / Beckers
Giles Bruce / beckershospitalreview - CMS has released updated telehealth guidance following the end of the 43-day government shutdown. Here are four things to know from the November FAQ: 1. CMS will retroactively pay for telehealth claims for services rendered amid the fiscal standoff. 2. Me…
#healthcare #publichealth #governmentpolicy
Saturday, November 22, 2025, 12:21 am / permalink 16202 / 2 stories in 3 months
CMS ups hospital outpatient rates 2.6%, expands site-neutral payments in 2026: 14 notes / Beckers
Alan Condon / beckershospitalreview - CMS on Nov. 21 finalized its Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System rule for 2026, enacting reforms to boost price transparency and expand outpatient access. Fourteen things to know: Hospital outpatien…
#healthcare #publichealth #governmentpolicy
Saturday, November 22, 2025, 12:21 am / permalink 16203 / 2 stories in 3 months